CHICAGO, Oct. 13 /PRNewswire-FirstCall/ -- Allscripts-Misys Healthcare
Solutions, Inc. ("Allscripts" or the "Company") (Nasdaq: MDRXD), the leading
provider of clinical software, connectivity and information solutions that
physicians use to improve healthcare, announced today that The Nasdaq OMX
Group, Inc ("Nasdaq") has temporarily changed Allscripts' ticker symbol to
"MDRXD". It is anticipated that Nasdaq will change Allscripts' ticker back to
"MDRX" on October 20, 2008, the first trading day after the date on which the
previously announced special cash dividend of $5.23 per share will be paid.
Allscripts common stock is now trading without the right to the special cash
dividend.
About Allscripts
Allscripts-Misys Healthcare Solutions, Inc. (NASDAQ: MDRXD) uses
innovation technology to bring health to healthcare. More than 150,000
physicians, 700 hospitals and nearly 7,000 post-acute and homecare
organizations utilize Allscripts-Misys to improve the health of their patients
and their bottom line. The company's award-winning solutions include
electronic health record, electronic prescribing, revenue cycle management,
practice management, document management, medication services, hospital care
management, emergency department information systems and homecare automation.
Allscripts is the brand name of Allscripts-Misys Healthcare Solutions, Inc. To
learn more, visit http://www.allscripts.com.
Forward-Looking Statements
This news release may contain forward-looking statements within the
meaning of the federal securities laws. Statements regarding future events,
developments, the Company's future performance, as well as management's
expectations, beliefs, intentions, plans, estimates or projections relating to
the future are forward-looking statements within the meaning of these laws.
These forward-looking statements are subject to a number of risks and
uncertainties, some of which are outlined below. As a result, actual results
may vary materially from those anticipated by the forward-looking statements.
Among the important factors that could cause actual results to differ
materially from those indicated by such forward-looking statements are: the
volume and timing of systems sales and installations; length of sales cycles
and the installation process; the possibility that products will not achieve
or sustain market acceptance; the timing, cost and success or failure of new
product and service introductions, development and product upgrade releases;
competitive pressures including product offerings, pricing and promotional
activities; our ability to establish and maintain strategic relationships;
undetected errors or similar problems in our software products; compliance
with existing laws, regulations and industry initiatives and future changes in
laws or regulations in the healthcare industry; possible regulation of the
Company's software by the U.S. Food and Drug Administration; the possibility
of product-related liabilities; our ability to attract and retain qualified
personnel; our ability to identify and complete acquisitions, manage our
growth and integrate acquisitions; the ability to recognize the benefits of
the merger with Misys Healthcare Systems, LLC ("MHS"); the integration of MHS
with the Company and the possible disruption of current plans and operations
as a result thereof; maintaining our intellectual property rights and
litigation involving intellectual property rights; risks related to
third-party suppliers; our ability to obtain, use or successfully integrate
third-party licensed technology; breach of our security by third parties; and
the risk factors detailed from time to time in our reports filed with the
Securities and Exchange Commission, including our 2007 Annual Report on Form
10-K available through the Web site maintained by the Securities and Exchange
Commission at http://www.sec.gov. The Company undertakes no obligation to
update publicly any forward-looking statement, whether as a result of new
information, future events or otherwise.
.gif)
